These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2350533)

  • 1. The pharmacokinetics of midazolam in patients with congestive heart failure.
    Patel IH; Soni PP; Fukuda EK; Smith DF; Leier CV; Boudoulas H
    Br J Clin Pharmacol; 1990 May; 29(5):565-9. PubMed ID: 2350533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midazolam pharmacokinetics following intravenous and buccal administration.
    Schwagmeier R; Alincic S; Striebel HW
    Br J Clin Pharmacol; 1998 Sep; 46(3):203-6. PubMed ID: 9764959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects.
    Pentikäinen PJ; Välisalmi L; Himberg JJ; Crevoisier C
    J Clin Pharmacol; 1989 Mar; 29(3):272-7. PubMed ID: 2723115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and preliminary observations of behavioral changes following administration of midazolam to dogs.
    Court MH; Greenblatt DJ
    J Vet Pharmacol Ther; 1992 Dec; 15(4):343-50. PubMed ID: 1487833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas.
    Aarnes TK; Fry PR; Hubbell JA; Bednarski RM; Lerche P; Chen W; Bei D; Liu Z; Lakritz J
    Am J Vet Res; 2013 Feb; 74(2):294-9. PubMed ID: 23363357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of congestive heart failure on the pharmacokinetics of cibenzoline.
    Massarella JW; Silvestri T; DeGrazia F; Miwa B; Keefe D
    J Clin Pharmacol; 1987 Mar; 27(3):187-92. PubMed ID: 3680572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of midazolam in paediatric patients.
    Payne K; Mattheyse FJ; Liebenberg D; Dawes T
    Eur J Clin Pharmacol; 1989; 37(3):267-72. PubMed ID: 2612542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients.
    Malacrida R; Fritz ME; Suter PM; Crevoisier C
    Crit Care Med; 1992 Aug; 20(8):1123-6. PubMed ID: 1643892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of a thigh tourniquet on the pharmacokinetics of midazolam].
    Schmitt HJ; Batz GM; Götz H; Knoll RJ; Danner UG; Härtl LM
    Anaesthesist; 1991 Feb; 40(2):79-84. PubMed ID: 2048708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacokinetics of midazolam following intramuscular administration].
    Behne M; Janshon G; Asskali F; Förster H
    Anaesthesist; 1989 Jun; 38(6):278-84. PubMed ID: 2764268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of midazolam after intravenous administration to horses.
    Hubbell JA; Kelly EM; Aarnes TK; Bednarski RM; Lerche P; Liu Z; Lakritz J
    Equine Vet J; 2013 Nov; 45(6):721-5. PubMed ID: 23489241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.
    Pentikis HS; Connolly M; Trapnell CB; Forbes WP; Bettenhausen DK
    Pharmacotherapy; 2007 Oct; 27(10):1361-9. PubMed ID: 17896891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
    Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of flumazenil and midazolam.
    Jones RD; Chan K; Roulson CJ; Brown AG; Smith ID; Mya GH
    Br J Anaesth; 1993 Mar; 70(3):286-92. PubMed ID: 8471371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age, gender, and obesity on midazolam kinetics.
    Greenblatt DJ; Abernethy DR; Locniskar A; Harmatz JS; Limjuco RA; Shader RI
    Anesthesiology; 1984 Jul; 61(1):27-35. PubMed ID: 6742481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy.
    Bell DM; Richards G; Dhillon S; Oxley JR; Cromarty J; Sander JW; Patsalos PN
    Epilepsy Res; 1991; 10(2-3):183-90. PubMed ID: 1817958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
    Berg AK; Myrvik MJ; Van Ess PJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients.
    Driessen JJ; Vree TB; Guelen PJ
    Acta Anaesthesiol Belg; 1991; 42(3):149-55. PubMed ID: 1767626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.